SEI Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-219
| Closed | – | – | 2689 |
|
|
2018
Q3 | $0 | Sell |
219
-4,359
| -95% | -$15.7K | ﹤0.01% | 3790 |
|
|
2018
Q2 | $17K | Buy |
4,578
+71
| +2% | +$346 | ﹤0.01% | 2850 |
|
|
2018
Q1 | $18K | Buy |
4,507
+4,167
| +1,226% | +$19.4K | ﹤0.01% | 2686 |
|
|
2017
Q4 | $2K | Hold |
340
| – | – | ﹤0.01% | 3165 |
|
|
2017
Q3 | $2K | Sell |
340
-111,428
| -100% | -$801K | ﹤0.01% | 3032 |
|
|
2017
Q2 | $808K | Buy |
111,768
+111,277
| +22,663% | +$695K | ﹤0.01% | 1492 |
|
|
2017
Q1 | $3K | Sell |
491
-82,700
| -99% | -$453K | ﹤0.01% | 2685 |
|
|
2016
Q4 | $488K | Buy |
83,191
+82,700
| +16,843% | +$452K | ﹤0.01% | 1584 |
|
|
2016
Q3 | $3K | Hold |
491
| – | – | ﹤0.01% | 2624 |
|
|
2016
Q2 | $3K | Buy |
491
+447
| +1,016% | +$2.5K | ﹤0.01% | 2462 |
|
|
2016
Q1 | $0 | Hold |
44
| – | – | ﹤0.01% | 2734 |
|
|
2015
Q4 | $0 | Sell |
44
-1,491
| -97% | -$7.08K | ﹤0.01% | 2795 |
|
|
2015
Q3 | $5K | Buy |
1,535
+365
| +31% | +$2.44K | ﹤0.01% | 2285 |
|
|
2015
Q2 | $12K | Buy |
1,170
+951
| +434% | +$10.2K | ﹤0.01% | 1893 |
|
|
2015
Q1 | $2K | Buy |
219
+175
| +398% | +$2.25K | ﹤0.01% | 2165 |
|
|
2014
Q4 | $1K | Buy |
+44
| New | +$682 | ﹤0.01% | 2172 |
|
SEI Investments's KERX Position: Q4 2018 in Review
SEI Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 219 shares.
SEI Investments first reported a position in KERX in Q4 2014 and held it in 16 quarters. The position peaked at $808K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- SEI Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- SEI Investments sold 219 Keryx Biopharmaceuticals Inc shares in Q4 2018.
- SEI Investments first reported a position in Keryx Biopharmaceuticals Inc in Q4 2014 and held it in 16 quarters.
- SEI Investments's Keryx Biopharmaceuticals Inc position peaked at $808K in Q2 2017.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on SEI Investments's 13F filing for Q4 2018, filed 13 Feb 2019.